Five things for pharma marketers to know: Friday, October 16, 2015

Five things for pharma marketers to know: Friday, October 16, 2015

The NIH plans to fund fewer but more meaningful studies; the FDA asks for more data about AstraZeneca diabetes drug; payers continue to deny coverage for new hep.-C treatments

Five things for pharma marketers to know: Tuesday, October 13, 2015

Five things for pharma marketers to know: Tuesday, October 13, 2015

Lilly stops trial for experimental heart drug; Turing misses deadline to respond to lawmakers about price increase of Daraprim; the FDA expands indication for Opdivo

Mobile sensors and digital devices may cut costs at GSK

Mobile sensors and digital devices may cut costs at GSK

A GSK manager said that bringing digital devices to clinical trials could lower the cost of bringing medicines to patients.

Diabetes device firm Intarcia taps former ICC Lowe CEO Viviano as marketing lead

Diabetes device firm Intarcia taps former ICC Lowe CEO Viviano as marketing lead

Longtime ICC leader Viviano moves to the client side to help the start-up build its marketing team and become a commercial contender.